NCT05329584 · Stryker Endoscopy
InSpace Accelerated Rehabilitation Study
(iAccelerate)
What this study is about
This is a forward-looking, parallel group, where both patients and doctors know the treatment given, multi- center, randomly assigned study to assess two accelerated rehabilitation programs for use with the InSpace device in the treatment of full thickness Massive, Irreparable Rotator Cuff Tears (MIRCTs) performed during an arthroscopic procedure.
View original scientific description
This is a prospective, parallel group, open-label, multi- center, randomized study to assess two accelerated rehabilitation programs for use with the InSpace device in the treatment of full thickness Massive, Irreparable Rotator Cuff Tears (MIRCTs) performed during an arthroscopic procedure.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Subjects MUST meet ALL the following criteria to be included in the study:
- The subject has signed the IRB approved Informed Consent Form (ICF) specific to this study prior to enrollment
- Is male or female ≥ sixty-five (65) years of age
- Positive diagnostic imaging by MRI within 9 months of enrollment of the index shoulder indicating a full thickness MRCT:
- Measuring ≥ 5 cm in diameter
- Involving ≥ two tendons
- Functional deltoid muscle and preserved passive range of motion on physical examination
- Documented VAS score \> 30 mm pain
- Failed non-operative treatment of at least 3 months from the initial treatment to include one or more of the following:
- Oral analgesics
- Anti-inflammatory medication (e.g., ibuprofen, naproxen)
- Corticosteroid injection(s)
- Physical therapy
- Activity modification
- Rest (sling used)
- Must be able to read and understand the approved Informed Consent Form (written and oral)
- Must be in general good health (as determined by the Investigator) based on screening assessments and medical history
- Must be independent, ambulatory, and can comply with all post-operative evaluations, visits, and electronic database collection Intra-operative Inclusion Criteria Subjects MUST meet the following criteria to be randomized in the study:
- Full thickness tear
- Tear size ≥ 5 cm in diameter
- Tear involving ≥ two tendons
Exclusion criteria
- Subjects will be excluded from the study, if they meet ANY of the following individual exclusion criteria:
- Known allergy to the device material (copolymer of PLA (poly (lactic acid) and -ε-caprolactone)
- Evidence of the following conditions:
- Severe gleno-humeral or acromio-humeral arthritis
- Full thickness cartilage loss as seen on MRI
- History within the past 5 years of anterior or posterior shoulder subluxation or dislocation as determined by history, examination, or radiographic findings
- Pre-existing deltoid defect or deltoid palsy
- Major joint trauma, infection, or necrosis
- Partial thickness tears of the supraspinatus
- Fully reparable rotator cuff tear \[Tear of less than 5 cm in diameter (or \< 4 cm2) with retractable tendon that can be fully repaired\]
- Known neurovascular compromise
- Complete deltoid muscle palsy
- Traumatic muscle tears of the pectoralis or deltoid
- The subject requires concomitant:
- Subscapularis repair
- Labral repair of any type
- Biceps tenodesis
- Previous surgery of the index shoulder in the past 1 year, excluding diagnostic arthroscopy
- The subject's condition is bilateral and rotator cuff repair is scheduled or to be scheduled over the course of this study for the contra lateral shoulder
- Major medical condition that could affect quality of life and influence the results of the study (e.g., rheumatoid arthritis)
- The subject has documented evidence of a history (e.g., liver testing) of drug/alcohol abuse within 12 months of enrollment
- The subject's condition represents a worker's compensation case
- The subject is currently involved in a health-related litigation procedure
- Females of child-bearing potential who are pregnant or plan to become pregnant.
- Concurrent participation in an investigational clinical study one month prior to enrollment or during the entire study period
- The subject is physically or mentally compromised (e.g., currently being treated for a psychiatric disorder, senile dementia, Alzheimer's disease, etc.), to the extent that the Investigator judges the subject to be unable or unlikely to remain compliant to follow-up
- The subject is receiving prescription narcotic pain medication for conditions unrelated to the index shoulder condition
- The subject currently has an acute infection in the area surrounding the surgical site.
- Baseline WORC score less than 420 Intra-operative Exclusion Criteria: Subjects will not be randomized and will be terminated from the study if they meet ANY of the following individual intra-operative exclusion criteria:
- Rotator cuff is/presents with:
- Fully reparable with adequate tissue and muscle quality (equivalent to Goutallier stage 1 or 2)
- Partial thickness tear of the supraspinatus
- Evidence of significant osteoarthritis
- The subject requires concomitant:
- Subscapularis repair
- Labral repair of any type
- Biceps tenodesis
- Coracoacromial ligament functional deficiency or shoulder instability is identified
Where
- Phoenix, Arizona
- Little Rock, Arkansas
- Englewood, Colorado
- Fort Lauderdale, Florida
- West Palm Beach, Florida
- Atlanta, Georgia
- Chicago, Illinois
- Rochester, Minnesota
- New York, New York
- Philadelphia, Pennsylvania
- San Antonio, Texas
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced May 29, 2025 · Source of record for eligibility and locations